Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pituitary
Published in: Pituitary 2/1999

01-06-1999

Estrogen Receptor Beta mRNA Expression in Normal and Adenomatous Pituitaries

Authors: Neil JL Gittoes, Christopher J McCabe, Michael C Sheppard, Jayne A Franklyn

Published in: Pituitary | Issue 2/1999

Login to get access
Metadata
Title
Estrogen Receptor Beta mRNA Expression in Normal and Adenomatous Pituitaries
Authors
Neil JL Gittoes
Christopher J McCabe
Michael C Sheppard
Jayne A Franklyn
Publication date
01-06-1999
Publisher
Kluwer Academic Publishers
Published in
Pituitary / Issue 2/1999
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1023/A:1009928420333

Other articles of this Issue 2/1999

Pituitary 2/1999 Go to the issue

OriginalPaper

Efficacy of Combined Treatment with Lanreotide and Cabergoline in Selected Therapy-Resistant Acromegalic Patients

OriginalPaper

Results of a European Multicentre Study with Sandostatin® LAR® in Acromegalic Patients

OriginalPaper

The Fifth International Pituitary Congress - June 1998

OriginalPaper

Estrogen Receptors in Prolactinomas: A Clinico-Pathological study

OriginalPaper

Leptin after IGF-I Generation Test in a Patient with Hypopituitarism and Myotonic Dystrophy Disease

OriginalPaper

Cost-effectiveness and accuracy of the tests used in the differential diagnosis of Cushing's syndrome.
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits